6th Annual Drug Development Congress 2014(June 2-3, Geneva Switzerland)

6th Annual Drug Development Congress 2014

2&3 June 2014, Geneva, Switzerland

 

http://www.drugdevelopment-congress1.com/

 

     ►  250 delegates representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions

     ►  20 presentations, case studies and panel discussions focused on the key issues in drug discovery and medicinal chemistry

     ►  2 Interactive Streams:
          ▪  Drug Development: Overcoming Key Challenges
          ▪  Improving Decision Making & Fostering Collaboration

     ►  14 prescheduled one to one meetings, Q&A sessions and exhibition spaces creating a unique platform for business and scientific discussion

 

Oxford Global Conferences are proud to present the 6^th Annual Drug Development Congress, taking place on the  2 & 3 June 2014 in Geneva.

 

It is estimated that the average drug costs the world’s leading pharmaceutical companies at least $4 billion to develop. Amid fears that the current large pharma model is not working, this event focuses on attempts to break down discovery and development boundaries and promote knowledge share between therapy areas.

 

On Day One, our expert speakers will discuss key areas for improvement in drug development, including translational modelling, safety & efficacy prediction and PK/PD testing. Delegates will also hear innovation case studies covering NGS applications in drug development and the development of the first approved gene therapy in Europe.

 

Day Two will cover current methods to improve decision making in drug development; from advances in biomarker technology, to the streamlining of sample analysis, to new knowledge management frameworks. Our expert speakers will also present collaboration case studies, discussing both external and internal attempts to harness complimentary skills and reduce late stage failure.

 

To maintain the extensive networking opportunities enjoyed by last year’s delegates, the development congress will once again be co-located with our discovery summit. The 15^th Annual Drug Discovery Leaders’ Summit has a long-held association with the leaders in medicinal chemistry and drug design. This year’s event will focus on innovation. Experts will discuss how new developments in screening, assay development, structure-activity analysis and anti-target effect prediction will influence the success of discovery portfolios.

 

Who Will Attend

 

The 6^th Annual Drug Development Congress is an exclusive event designed for senior level attendees from leading pharmaceutical and biotechnology organisations, along with highly esteemed members of academic and government institutions. Delegates typically include VPs, Directors and Global Heads of:

ADME Biomarkers Biopharmaceuticals Imaging Immunogenicity Modelling & Simulation

Pharmacology PK/PD Research & Development Safety Toxicology Translational Research

Delegates will benefit from…

• An executive format that facilitates idea exchange and discussion of relevant experiences through case study presentations and strategic discussions
• Networking opportunities and knowledge share with highly-esteemed peers
• Pre-scheduled one-to-one meetings with solution providers offering an opportunity to forge partnerships and discover innovative solutions
• Post event follow up providing all documentation from the meeting and re-booking discounts
• Tailor-made agenda – hand pick any conference and panel sessions you wish to attend

Contact Oxford Global
Oxford Global Conferences

All general enquiries
Tel: +44 (0)1865 248455
Fax: +44 (0)1865 250985

For speaker opportunities contact c.roberts@oxfordglobal.co.uk
For sponsorship opportunities contact sponsorship@oxfordglobal.co.uk